According to the latest report by IMARC Group,the global pneumococcal vaccine market size grew at a CAGR of 5% during 2015-2020.Pneumococcal vaccines are used to enhance immunization against the bacterium streptococcus pneumoniae that causes meningitis, sepsis and pneumonia. There are two types of pneumococcal vaccines, namely pneumococcal conjugate (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).